Showing 381-390 of 5598 results for "".
Return of Auras Following Treatment of Focal-Onset Seizures with Responsive Neurostimulation
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/return-of-auras-following-treatment-of-focal-onset-seizures-with-responsive-neurostimulation/32017/So Cute You Could...Crush It?
https://reachmd.com/programs/clinicians-roundtable/so-cute-you-couldcrush-it/10699/There’s a name for the urge you get to pinch a baby's face or squeeze a puppy. But it doesn’t just have a name—it could also be neurologically rooted.Identification, Management, and Prevention of Polypharmacy in Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/identification-management-and-prevention-of-polypharmacy-in-multiple-sclerosis/32088/Rational prescription practices in multiple sclerosis treatment are key to the prevention and mitigation of polypharmacy.Evolving Treatment Approaches in EGFRm NSCLC
https://reachmd.com/programs/medical-industry-feature/evolving-treatment-approaches-in-egfrm-nsclc/18476/As the treatment landscape for EGFR-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) evolves,1-3 additional therapy options like antibody-drug conjugates (ADCs) could show promise in meeting unmet needs.4,5 DATROWAY, also known by its generic name datopotamab deruxtecan-dlnkExploring the Emergency Use Authorization for a Monoclonal Antibody Cocktail for COVID-19
https://reachmd.com/programs/the-drug-report/exploring-the-emergency-use-authorization-for-a-monoclonal-antibody-cocktail-for-covid-19/12025/Here’s what led the FDA to issue an EUA for the coadministration of casirivimab and imdevimab to block COVID-19’s attachment and entry into cells.Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
https://reachmd.com/programs/neurofrontiers/quality-of-life-challenges-in-gmg-care-navigating-the-invisible-burden/35493/Generalized myasthenia gravis (gMG) presents with highly variable symptoms that can significantly impact a patient’s quality of life, often in ways that are invisible to others. That’s why Dr. Maxwell Levy joins us to discuss these unmet needs and how we can address them with various clinical strateNavigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/navigating-metastatic-breast-cancer-care-key-factors-in-decision-making/35458/Treatment decisions in metastatic breast cancer hinge on tumor subtype, clinical characteristics, disease burden, and patient preferences. Join Dr. Paolo Tarantino as he explains evidence-based approaches for sequencing therapy across treatment lines while balancing efficacy, toxicity, and individuaNatural Fix: Rediscovering 'Valuable' Foods Our Bodies Need
https://reachmd.com/programs/primary-care-today/natural-fix-rediscovering-valuable-foods-our-bodies-need/10159/"You are what you eat" is a common phrase most of us have heard before but never really questioned…until now.Navigating Diagnostic Challenges in Food Protein-Induced Enterocolitis Syndrome
https://reachmd.com/programs/frontlines-food-allergies/navigating-diagnostic-challenges-in-food-protein-induced-enterocolitis-syndrome/30041/Food protein-induced enterocolitis syndrome (FPIES) is a rare, non-IgE-mediated food allergy in infants and young children that causes delayed, severe gastrointestinal symptoms without typical allergic signs. Learn about the challenges associated with diagnosing FPIES with Dr. Anna Nowak-Wegryzn, PrNavigating the Road Toward Healthcare Reform: Single-Payer Pros & Cons
https://reachmd.com/programs/voices-from-american-medicine/navigating-the-road-toward-healthcare-reform-single-payer-pros-cons/11204/Which healthcare reform policy stands a better chance of improving patient care: a single-payer model, a privatized one, or something in between?